SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001479290-15-000004
Filing Date
2015-10-16
Accepted
2015-10-16 17:02:16
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 s-3.htm S-3 272181
2 EXHIBIT 5.1 exhibit51.htm EX-5.1 6263
3 EXHIBIT 23.1 exhibit231.htm EX-23.1 2517
4 GRAPHIC rvncimage1.jpg GRAPHIC 30384
5 GRAPHIC rvncimage3.jpg GRAPHIC 18131
  Complete submission text file 0001479290-15-000004.txt   348865
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-207469 | Film No.: 151162505
SIC: 2834 Pharmaceutical Preparations